Decreased inflammation: Weight loss reduces the chronic inflammation associated with obesity, which improves insulin signaling at the cellular level
GLP-1 drugs continue to dominate the pharmaceutical landscape
Fortunately, scientists at Augusta Universitys Medical College of Georgia are conducting targeted research around the pathogens that cause Alzheimers
The clinical significance of this is unknown, as only 7-day dosing has been tested in trials
For example, omega 3 fatty acids are known to exert anti-inflammatory effects and protect cardiovascular health, effectively complementing the weight loss benefits of GLP-1 therapy
Things your clinician will specifically look out for include any allergy to the active ingredient in the new medication (tirzepatide in Mounjaro, semaglutide in Wegovy), any serious reactions to your current medication such as pancreatitis or a severe allergic reaction, and whether you are currently pregnant, planning to become pregnant, or breastfeeding